RE: Winterplex6 Dec 2022 23:26
This went on glassdor today in response to comments
"Novacyt is interested primarily in technologies applied to human infectious disease diagnostics and screening, and adjacent markets. These include: Respiratory, Gastrointestinal, Transplant, Insect-borne diseases. We are also considering additional unmet needs in infectious diseases including sexually transmitted infections (STI), urinary tract infections (UTI), hospital acquired infections, meningitis/encephalitis and sepsis. There are some business areas which we have now withdrawn from, as they did not sit in our focus, which is very much on infectious diseases. "